tykhr
sign in
free sign up
Acrivon Therapeutics, Inc. Common Stock
Biotechnology
Healthcare
ACRV
38.11 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
1.32
52 week high
9.98
high
1.67
52 week low
1.36
low
1.30
growth
-79.15 %
previous Close
1.36
P/E ratio
market cap
209 M
div yield
0
usd
Sep 2024
qoq
revenue
0.00 %
net incoming
-22.44 M
-19.38 %
eps
0.00 %
-13.46 %
eps surprise
0.24 %
net profit margin
-2244100000.00 %
0.00 %
operating incoming
-25.14 M
-17.27 %
net change in cash
-2.40 M
-111.19 %
cash on hand
43.42 M
-5.63 %
cost of revenue
0.00 %
top